October 2015 - FDA approves two drugs - Esbriet (Pirfenidone) and Ofev (Nintedanib) to treat idiopathic pulmonary fibrosis
When you try to find as much as you can about pulmonary fibrosis in general or specifically idiopathic pulmonary fibrosis (IPF), you will find that there is a lot of information on the web. Most is scattered over many different websites but we believe that much of this information is:
We have tried to establish a new style of website (a platform without requests for donations or any commercial activity) where we try to focus on your questions and give you a wealth of information. We don't put too much effort in making the website slick and modern looking because simplicity is the most important thing for you right now. Links are links and we didn't beautify them. Info and news (gathered from all over the world) are updated as often as possible.
This means that there’s a role for you, patient, family, caregiver friend or professional to inform us on anything you find anywhere (national or international) that we may have overlooked. Please use the contact page to send us anything on news, medications, clinical trials, hospitals, support groups, links, blogs, events, etc. or even to correct spelling errors. Don’t be afraid to criticize the site because we need your input to make this site your best information source.
Keep in mind that we're not physicians and that all information on this website is to be used only in your discussions with your physicians etc. Please read the disclaimer at the bottom of each page.
Thanks and good luck.
If you like what we're doing - like us on Facebook!! - https://www.facebook.com/IPFToday
"Yesterday is history. Tomorrow is a mystery. Today is a gift. That's why we call it 'The Present'."
“Happiness is not the absence of problems but the ability to deal with them.”
H. Jackson Brown, Jr.